Peer-reviewed veterinary case report
CuSNanozyme Efficiently Inactivating Drug-Resistant Bacteria on Mouse Wound Models through Photodynamic and Photothermal Synergetic Therapy.
- Journal:
- Advanced science (Weinheim, Baden-Wurttemberg, Germany)
- Year:
- 2025
- Authors:
- Li, Xueya et al.
- Affiliation:
- College of Life · China
- Species:
- cat
Abstract
The rapid emergence of drug-resistant bacteria has outpaced the development of traditional antibiotics, necessitating the exploration of more effective therapeutic strategies. In this study, the design of a CuSmultifunctional nanozyme, activated by near-infrared (NIR) light is presented, that demonstrates enhanced antibacterial activity. CuSis synthesized with varying defect structures by utilizing different templates, which substantially optimize its absorption to HOand lipopolysaccharides (LPS) molecules. This process generates an optimal electronic structure, producing efficient antibacterial activity through photodynamic and photothermal synergetic processes. Specifically, the CuSnanozyme with dual defects (VCu and VCuCuCuSSS) exhibits peroxidase-like (POD), catalase-like (CAT), and GSH-depletion properties, effectively inactivating drug-resistant bacteria such as Pseudomonas aeruginosa. Notably, in a mouse wound model infected with P. aeruginosa, the nanozyme demonstrates significant antibacterial efficacy, promoting wound healing under NIR light. This multifunctional CuSnanozyme presents a promising new strategy for combating drug-resistant bacterial infections.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/40488308/